World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
64
Citations
21137
World Ranking
2896
National Ranking
27

Zhiwei Chen publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Zhiwei Chen sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 281 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Zhiwei Chen D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Zhiwei Chen sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 64 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Zhiwei Chen is affiliated with the University of Hong Kong in China and has contributed extensively to the field of medicine, with a focus on infectious diseases, molecular biology, immunology, epidemiology, and oncology. Their research spans multiple interrelated domains, including SARS-CoV-2 and COVID-19 research, COVID-19 clinical studies, immune cell function and interaction, immunotherapy and immune responses, viral detection methods, epigenetics, and RNA modifications related to cancer.

The scientist has coauthored numerous publications alongside several frequent collaborators, notably Kwok-Yung Yuen, Runhong Zhou, Kelvin Kai-Wang To, Jasper Fuk-Woo Chan, and Li Liu. Their articles have appeared in a variety of scientific venues, with frequent contributions to the SSRN Electronic Journal, bioRxiv (Cold Spring Harbor Laboratory), Nature Communications, EBioMedicine, and Research Square (Research Square).

Key recent papers include:

  • Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study (2020, The Lancet Infectious Diseases)
  • Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike (2020, Nature)
  • Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility (2020, Clinical Infectious Diseases)
  • Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5 (2022, Nature)
  • Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses (2020, Immunity)

Zhiwei Chen's body of work is primarily situated within medicine, with 373 publications contributing to this field. Among these, 120 publications relate specifically to infectious diseases, highlighting the scientist's focus on viral pathogens and their clinical and immunological impact.

The scientist's frequent publication venues provide a view of their active engagement with open research platforms and peer-reviewed journals that focus on the biomedical sciences and translational medicine. The variety of venues and topics reflects a multidisciplinary approach tailored to understanding COVID-19 pathogenesis, immune responses, and potential therapeutic interventions.

Frequent co-authors:

  • Kwok-Yung Yuen
  • Runhong Zhou
  • Kelvin Kai-Wang To
  • Jasper Fuk-Woo Chan
  • Li Liu

Frequent publication venues:

  • SSRN Electronic Journal
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • EBioMedicine
  • Research Square (Research Square)

Main fields of study:

  • Medicine

Subfields of study:

  • Infectious Diseases
  • Molecular Biology
  • Immunology
  • Epidemiology
  • Oncology

Main research topics:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Immune Cell Function and Interaction
  • Immunotherapy and Immune Responses
  • SARS-CoV-2 detection and testing
  • Epigenetics and DNA Methylation
  • RNA modifications and cancer

Best Publications

  • Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.

    Kelvin Kai Wang To;Owen Tak Yin Tsang;Wai Shing Leung;Anthony Raymond Tam

  • Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike.

    Lihong Liu;Pengfei Wang;Manoj S. Nair;Jian Yu

  • Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility.

    Jasper Fuk Woo Chan;Jasper Fuk Woo Chan;Jasper Fuk Woo Chan;Anna Jinxia Zhang;Shuofeng Yuan;Vincent Kwok Man Poon

  • Anti–spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection

    Li Liu;Qiang Wei;Qingqing Lin;Jun Fang

  • Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses

    Runhong Zhou;Kelvin Kai Wang To;Yik Chun Wong;Li Liu

  • Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR

    Stefan Pöhlmann;Jie Zhang;Frédéric Baribaud;Zhiwei Chen

  • Epithelial Cells Lining Salivary Gland Ducts Are Early Target Cells of Severe Acute Respiratory Syndrome Coronavirus Infection in the Upper Respiratory Tracts of Rhesus Macaques

    Li Liu;Qiang Wei;Xavier Alvarez;Haibo Wang

  • Genetically Divergent Strains of Simian Immunodeficiency Virus Use CCR5 as a Coreceptor for Entry

    Z Chen;P Zhou;D D Ho;N R Landau

  • International AIDS Society global scientific strategy: towards an HIV cure 2016

    Steven G Deeks;Sharon R Lewin;Anna Laura Ross;Jintanat Ananworanich

  • SARS-CoV-2 Omicron BA.2.12.1, BA.4, and BA.5 subvariants evolved to extend antibody evasion

    Unknown

  • Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis

    Joris Hemelaar;Ramyiadarsini Elangovan;Jason Yun;Leslie Dickson-Tetteh

  • The changing face of HIV in China

    Lin Lu;Manhong Jia;Yanling Ma;Li Yang

  • Genetic characterization of New West African simian immunodeficiency virus SIVsm: geographic clustering of household-derived SIV strains with human immunodeficiency virus type 2 subtypes and genetically diverse viruses from a single feral sooty mangabey troop.

    Z Chen;P Telfier;A Gettie;P Reed

  • Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus-infected sooty mangabeys.

    Zhiwei Chen;Amara Luckay;Donald L. Sodora;Paul Telfer

  • Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction.

    Siu Ying Lau;Pui Wang;Bobo Wing Yee Mok;Anna Jinxia Zhang

  • Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.

    Zhiwei Chen;Linqi Zhang;Chuan Qin;Lei Ba

  • Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system.

    Man Lung Yeung;Jade Lee Lee Teng;Lilong Jia;Chaoyu Zhang

  • Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer

    Xu Chen;Jingtong Zhang;Weimei Ruan;Ming Huang

  • Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals

    Linqi Zhang;Fengwen Zhang;Wenjie Yu;Tian He

  • Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy

    Jingying Zhou;Man Liu;Hanyong Sun;Yu Feng

  • Chemokine Coreceptor Usage by Diverse Primary Isolates of Human Immunodeficiency Virus Type 1

    Linqi Zhang;Tian He;Yaoxing Huang;Zhiwei Chen

  • Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics.

    Richard Y. Kao;Wayne H.W. Tsui;Terri S.W. Lee;Julian A. Tanner

  • Dominance of HIV-1 subtype CRF01_AE in sexually acquired cases leads to a new epidemic in Yunnan province of China.

    Yong Zhang;Lin Lu;Lei Ba;Li Liu;Li Liu

Frequent Co-Authors

Kwok-Yung Yuen
Kwok-Yung Yuen University of Hong Kong
David D. Ho
David D. Ho Columbia University
Kelvin K. W. To
Kelvin K. W. To University of Hong Kong
Jasper F. W. Chan
Jasper F. W. Chan University of Hong Kong
Yaoxing Huang
Yaoxing Huang Columbia University
Kwok-Hung Chan
Kwok-Hung Chan University of Hong Kong
Linqi Zhang
Linqi Zhang Tsinghua University
Preston A. Marx
Preston A. Marx Tulane University
Chuan Qin
Chuan Qin Peking Union Medical College Hospital
Hin Chu
Hin Chu University of Hong Kong

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA often opens doors to various healthcare careers, especially in nursing and advanced practice roles. For those interested in expanding their clinical expertise, exploring an fnp to acnp bridge program online can be an efficient way to transition from Family Nurse Practitioner to Acute Care Nurse Practitioner roles.

Additionally, accelerated pathways like accelerated rn to np programs enable registered nurses to fast-track their education and enter nurse practitioner roles sooner, which can align well with immunology-focused specialties.

For those without a nursing background, there are options such as online adn programs for non nurses that offer a foundational entry into nursing careers while maintaining flexibility, ideal for students pursuing immunology-related fields.

Understanding compensation is also vital when exploring these pathways. Reliable information is available through dnp salary transparency, helping prospective students make informed decisions about investing in advanced nursing degrees.

Best Scientists Citing Zhiwei Chen

Trending Scientists

Recently Published Articles